BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

610 related articles for article (PubMed ID: 29194618)

  • 1. Narrower insight to SIRT1 role in cancer: A potential therapeutic target to control epithelial-mesenchymal transition in cancer cells.
    Choupani J; Mansoori Derakhshan S; Bayat S; Alivand MR; Shekari Khaniani M
    J Cell Physiol; 2018 Jun; 233(6):4443-4457. PubMed ID: 29194618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Celecoxib and sulindac inhibit TGF-β1-induced epithelial-mesenchymal transition and suppress lung cancer migration and invasion via downregulation of sirtuin 1.
    Cha BK; Kim YS; Hwang KE; Cho KH; Oh SH; Kim BR; Jun HY; Yoon KH; Jeong ET; Kim HR
    Oncotarget; 2016 Aug; 7(35):57213-57227. PubMed ID: 27528025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silent information regulator 1 suppresses epithelial-to-mesenchymal transition in lung cancer cells via its regulation of mitochondria status.
    Zhang J; Peng J; Kong D; Wang X; Wang Z; Liu J; Yu W; Wu H; Long Z; Zhang W; Liu R; Hai C
    Life Sci; 2021 Sep; 280():119716. PubMed ID: 34119539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SIRT1-ZEB1-positive feedback promotes epithelial-mesenchymal transition process and metastasis of osteosarcoma.
    Yu XJ; Guo XZ; Li C; Chong Y; Song TN; Pang JF; Shao M
    J Cell Biochem; 2019 Mar; 120(3):3727-3735. PubMed ID: 30304565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of SIRT1 in regulation of epithelial-to-mesenchymal transition in oral squamous cell carcinoma metastasis.
    Chen IC; Chiang WF; Huang HH; Chen PF; Shen YY; Chiang HC
    Mol Cancer; 2014 Nov; 13():254. PubMed ID: 25424420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A SUMOylation-dependent pathway regulates SIRT1 transcription and lung cancer metastasis.
    Sun L; Li H; Chen J; Dehennaut V; Zhao Y; Yang Y; Iwasaki Y; Kahn-Perles B; Leprince D; Chen Q; Shen A; Xu Y
    J Natl Cancer Inst; 2013 Jun; 105(12):887-98. PubMed ID: 23704280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysophosphatidic Acid Promotes Epithelial to Mesenchymal Transition in Ovarian Cancer Cells by Repressing SIRT1.
    Ray U; Roy SS; Chowdhury SR
    Cell Physiol Biochem; 2017; 41(2):795-805. PubMed ID: 28214851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SIRT1 induces EMT by cooperating with EMT transcription factors and enhances prostate cancer cell migration and metastasis.
    Byles V; Zhu L; Lovaas JD; Chmilewski LK; Wang J; Faller DV; Dai Y
    Oncogene; 2012 Oct; 31(43):4619-29. PubMed ID: 22249256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The expression of SIRT1 regulates the metastaticplasticity of chondrosarcoma cells by inducing epithelial-mesenchymal transition.
    Feng H; Wang J; Xu J; Xie C; Gao F; Li Z
    Sci Rep; 2017 Jan; 7():41203. PubMed ID: 28112277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PIASy mediates hypoxia-induced SIRT1 transcriptional repression and epithelial-to-mesenchymal transition in ovarian cancer cells.
    Sun L; Li H; Chen J; Iwasaki Y; Kubota T; Matsuoka M; Shen A; Chen Q; Xu Y
    J Cell Sci; 2013 Sep; 126(Pt 17):3939-47. PubMed ID: 23843607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SIRT1 promotes epithelial-mesenchymal transition and metastasis in colorectal cancer by regulating Fra-1 expression.
    Cheng F; Su L; Yao C; Liu L; Shen J; Liu C; Chen X; Luo Y; Jiang L; Shan J; Chen J; Zhu W; Shao J; Qian C
    Cancer Lett; 2016 Jun; 375(2):274-283. PubMed ID: 26975631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ZEB2 stably represses RAB25 expression through epigenetic regulation by SIRT1 and DNMTs during epithelial-to-mesenchymal transition.
    Skrypek N; Bruneel K; Vandewalle C; De Smedt E; Soen B; Loret N; Taminau J; Goossens S; Vandamme N; Berx G
    Epigenetics Chromatin; 2018 Nov; 11(1):70. PubMed ID: 30445998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oleuropein inhibits migration ability through suppression of epithelial-mesenchymal transition and synergistically enhances doxorubicin-mediated apoptosis in MCF-7 cells.
    Choupani J; Alivand MR; M Derakhshan S; Zaeifizadeh M; S Khaniani M
    J Cell Physiol; 2019 Jun; 234(6):9093-9104. PubMed ID: 30317622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic pancreatitis and pancreatic cancer demonstrate active epithelial-mesenchymal transition profile, regulated by miR-217-SIRT1 pathway.
    Deng S; Zhu S; Wang B; Li X; Liu Y; Qin Q; Gong Q; Niu Y; Xiang C; Chen J; Yan J; Deng S; Yin T; Yang M; Wu H; Wang C; Zhao G
    Cancer Lett; 2014 Dec; 355(2):184-91. PubMed ID: 25172416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From the Cover: l-Carnitine via PPARγ- and Sirt1-Dependent Mechanisms Attenuates Epithelial-Mesenchymal Transition and Renal Fibrosis Caused by Perfluorooctanesulfonate.
    Chou HC; Wen LL; Chang CC; Lin CY; Jin L; Juan SH
    Toxicol Sci; 2017 Dec; 160(2):217-229. PubMed ID: 28973641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SIRT1 expression regulates the transformation of resistant esophageal cancer cells via the epithelial-mesenchymal transition.
    Qin T; Liu W; Huo J; Li L; Zhang X; Shi X; Zhou J; Wang C
    Biomed Pharmacother; 2018 Jul; 103():308-316. PubMed ID: 29656187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SIRT1 induces tumor invasion by targeting epithelial mesenchymal transition-related pathway and is a prognostic marker in triple negative breast cancer.
    Jin MS; Hyun CL; Park IA; Kim JY; Chung YR; Im SA; Lee KH; Moon HG; Ryu HS
    Tumour Biol; 2016 Apr; 37(4):4743-53. PubMed ID: 26515337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging Drug Target In Pancreatic Cancer: Placing Sirtuin 1 on the Canvas.
    Giry-Laterriere M; Pinho AV; Eling N; Chantrill L; Rooman I
    Curr Cancer Drug Targets; 2015; 15(6):463-8. PubMed ID: 26282546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SIRT1 deacetylates KLF4 to activate Claudin-5 transcription in ovarian cancer cells.
    Zhang X; Chen J; Sun L; Xu Y
    J Cell Biochem; 2018 Feb; 119(2):2418-2426. PubMed ID: 28888043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alisertib induces cell cycle arrest and autophagy and suppresses epithelial-to-mesenchymal transition involving PI3K/Akt/mTOR and sirtuin 1-mediated signaling pathways in human pancreatic cancer cells.
    Wang F; Li H; Yan XG; Zhou ZW; Yi ZG; He ZX; Pan ST; Yang YX; Wang ZZ; Zhang X; Yang T; Qiu JX; Zhou SF
    Drug Des Devel Ther; 2015; 9():575-601. PubMed ID: 25632225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.